Opinion: A truce in the stem cell wars?
By Richard Hayes,
San Francisco Examiner
| 11. 24. 2006
The contentious midterm elections clearly left a mark on the politics of stem cell research, but it’s not clear what the mark signifies. Missouri’s closely watched stem cell initiative barely squeaked by with 51 per cent of the vote, despite a $30 million campaign financed almost entirely by a single wealthy couple. And in nine congressional races identified as high priority by stem cell research advocates, the stem cell candidate won in only four.
At the same time, at least 60 percent of all races in which stem cell research was an issue — including high-profile races for Congress, the Senate, and governorships — were won by the candidate supporting the research. And there’s no denying the frenzied TV and YouTube campaigning by partisans on all sides reinforced the identity of "stem cells" as an iconic trope of the culture wars.
Incoming Democratic House Speaker Nancy Pelosi has pledged a vote on federal stem cell funding "within the first 100 hours" of the new Congress. It appears there are now enough votes in the Senate to override a presidential veto...
Related Articles
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Nahlah Ayed, CBC Listen | 10.22.2025
Egg freezing is one of today’s fastest-growing reproductive technologies. It's seen as a kind of 'fertility insurance' for the future, but that doesn’t address today’s deeper feelings of uncertainty around parenthood, heterosexual relationships, and the reproductive path forward. In this...
By [cites CGS' Katie Hasson], KCBS Radio | 11.19.2025
This is Ask An Expert, where every weekday at 9:20am, KCBS Radio is giving you direct access to top experts in various fields. Today: Gene-editing technology allows scientists to work with DNA in unprecedented ways, but there are larger scientific...
By Antonio Regalado, MIT Technology Review | 10.31.2025
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the taboo technology.
The new company, called Preventive, is...